AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 223 filers reported holding AMICUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,440 | -7.3% | 5,875 | -4.3% | 0.00% | 0.0% |
| Q2 2023 | $77,068 | +14.2% | 6,136 | +0.8% | 0.00% | 0.0% |
| Q1 2023 | $67,494 | -9.4% | 6,086 | -0.2% | 0.00% | -33.3% |
| Q4 2022 | $74,469 | +101.3% | 6,099 | +72.4% | 0.00% | +50.0% |
| Q3 2022 | $37,000 | +5.7% | 3,537 | +9.5% | 0.00% | 0.0% |
| Q2 2022 | $35,000 | +9.4% | 3,229 | -3.9% | 0.00% | +100.0% |
| Q1 2022 | $32,000 | -17.9% | 3,361 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $39,000 | +3800.0% | 3,361 | +2446.2% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 132 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 132 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -66.7% | 132 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | +50.0% | 132 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 132 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |